Key facts
- Illumi Medical’s last known valuation is $8.0M (Jan 2026).
- It has raised $3.9M; the latest was Accelerator/Incubator ($2.3M) in Mar 2026.
- Notable investors include SMBC Venture Capital, UntroD, Mint (Japan), FASTAR, Aichi Deeptech Launchpad — 14 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 14 names
- ·Watchlist + deal alerts for Illumi Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Illumi Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Illumi Medical
Operator of a light-based medical treatment company intended to provide effective treatments for patients who have not been able to be treated before. The company's platform utilizes a variety of non-invasive and minimally invasive technologies, including laser therapy, radiofrequency skin tightening, ultrasound-based body sculpting, and physician-administered injectable skin boosters, enabling the regional healthcare market to access dermatological methods that address concerns such as aging, skin laxity, and facial contouring for individuals seeking natural-looking aesthetic improvements.
- Sector
- Healthcare
- HQ
- Nagoya, Japan
- Founded
- 2023
- Employees
- 9
- Website
- illumimedical.com/
- Ownership
- Privately Held (backing)
Illumi Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Illumi Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Illumi Medical in its N-PORT filings yet. We sweep new filings monthly.